Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Improving patient flow of people with rheumatoid arthritis has the potential to simultaneously improve health outcomes and reduce direct costs

Authors: R. Puchner, R. Hochreiter, H. Pieringer, A. Vavrovsky

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

In our current economic climate of scarce resources there is a lot of debate around the best - and most efficient - way of delivering care, which points patients towards the right physician at the earliest opportunity.
The aim of the study was to assess whether an improvement in the interdisciplinary management of rheumatoid arthritis (RA) has the potential to simultaneously improve health outcomes and reduce costs.

Methods

In a first step, we modelled the ways which lead patients with RA to the correct diagnosis, and the relevant specialist, respectively. On average, a patient experiences 3 GP visits before referral to a specialist. We compared this situation against a reconfiguration of current practice towards a more proactive identification and referral method with initiation of care by a rheumatologist early in the disease. We evaluated the impact of this reconfiguration on the number of RA patients diagnosed and the costs associated with the diagnostic process.

Result

Using data on epidemiology and Austrian practice patterns, we estimate a total of 5294 people with undifferentiated arthritis per year, of which 1765 suffer from RA. Modelling for diagnostic accuracy, we found that 1200 of these patients are initially misdiagnosed in a primary care setting and 95 at a rheumatologist. Our model found that a reconfiguration of current practice towards an approach of more integrated care has the potential to be not only cost-effective, but cost-saving: EUR 100,188 could be saved annually by exclusively adopting the new approach.

Conclusions

Our results show that by better directing the flow of people with RA, simultaneous clinical and economic benefits may be reaped:.
Literature
1.
go back to reference Bykerk V, Emery P. Delay in receiving rheumatology care leads to long term harm. Arthritis Rheum. 2010;62:3519–21.CrossRefPubMed Bykerk V, Emery P. Delay in receiving rheumatology care leads to long term harm. Arthritis Rheum. 2010;62:3519–21.CrossRefPubMed
2.
go back to reference Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, FIN-RACo Trial Group, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46:894–8.CrossRefPubMed Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, FIN-RACo Trial Group, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46:894–8.CrossRefPubMed
3.
go back to reference Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying, anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004;43:906–14. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying, anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004;43:906–14.
4.
go back to reference van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW, van der Helm-van Mil AH. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 2010;62(12):3537–46.CrossRefPubMed van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW, van der Helm-van Mil AH. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 2010;62(12):3537–46.CrossRefPubMed
5.
go back to reference van Nies JA, de Jong Z, van der Helm-van Mil AH, Knevel R, Le Cessie S, Huizinga TW. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology (Oxford). 2010;49(11):2210–6.CrossRef van Nies JA, de Jong Z, van der Helm-van Mil AH, Knevel R, Le Cessie S, Huizinga TW. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology (Oxford). 2010;49(11):2210–6.CrossRef
6.
go back to reference Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2014;73(3):492–509.CrossRefPubMed Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2014;73(3):492–509.CrossRefPubMed
7.
go back to reference Krüger K, Karberg K. Treat-to-target from the perspective of office-based rheumatology. Z Rheumatol. 2011;70(8):664–9.CrossRefPubMed Krüger K, Karberg K. Treat-to-target from the perspective of office-based rheumatology. Z Rheumatol. 2011;70(8):664–9.CrossRefPubMed
8.
go back to reference Westhoff G, Edelmann E, Kekow J, Zink A. Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist. Z Rheumatol. 2010;69(10):910–8.CrossRefPubMed Westhoff G, Edelmann E, Kekow J, Zink A. Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist. Z Rheumatol. 2010;69(10):910–8.CrossRefPubMed
9.
go back to reference Puchner R, Edlinger M, Mur E, Eberl G, Herold M, Kufner P, Puchner A, Puchner SE, Redlich K, Alkin A, Machold K. Interface management between general practitioners and rheumatologists-results of a survey defining a concept for future joint recommendations. PLoS One. 2016;11(1):e0146149. doi:10.1371/journal.pone.0146149. eCollection 2016.CrossRefPubMedPubMedCentral Puchner R, Edlinger M, Mur E, Eberl G, Herold M, Kufner P, Puchner A, Puchner SE, Redlich K, Alkin A, Machold K. Interface management between general practitioners and rheumatologists-results of a survey defining a concept for future joint recommendations. PLoS One. 2016;11(1):e0146149. doi:10.​1371/​journal.​pone.​0146149. eCollection 2016.CrossRefPubMedPubMedCentral
10.
go back to reference Gärtner M, Fabrizii JP, Koban E, Holbik M, Machold LP, Smolen JS, et al. Immediate access rheumatology clinic: efficiency and outcomes. Ann Rheum Dis. 2012;71(3):363–8.CrossRefPubMed Gärtner M, Fabrizii JP, Koban E, Holbik M, Machold LP, Smolen JS, et al. Immediate access rheumatology clinic: efficiency and outcomes. Ann Rheum Dis. 2012;71(3):363–8.CrossRefPubMed
11.
go back to reference Puchner R, Kaiser W, Janetschko R, Linkesch A, Steininger M, Tremetsberger R, Machold K. Efficacy and outcome of rapid access rheumatology consultation: an office-based pilot cohort study. J Rheumatol. 2016;43(6):1130–5. doi:10.3899/jrheum.151210.CrossRefPubMed Puchner R, Kaiser W, Janetschko R, Linkesch A, Steininger M, Tremetsberger R, Machold K. Efficacy and outcome of rapid access rheumatology consultation: an office-based pilot cohort study. J Rheumatol. 2016;43(6):1130–5. doi:10.​3899/​jrheum.​151210.CrossRefPubMed
12.
go back to reference Radner H, Smolen JS, Aletaha D. Remission in rheumatoid arthritis: benefit over low disease activity in patient reported outcomes and costs. Arthritis Res Ther. 2014;16(1):R56.CrossRefPubMedPubMedCentral Radner H, Smolen JS, Aletaha D. Remission in rheumatoid arthritis: benefit over low disease activity in patient reported outcomes and costs. Arthritis Res Ther. 2014;16(1):R56.CrossRefPubMedPubMedCentral
13.
go back to reference Kyburz D, Gabay C, Michel BA, Finckh A, physicians of SCQM-RA. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford). 2011;50(6):1106–10. Kyburz D, Gabay C, Michel BA, Finckh A, physicians of SCQM-RA. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford). 2011;50(6):1106–10.
15.
go back to reference Puchner R, Brezinschek HP, Herold M, Nothnagl T, Studnicka- Benke A, Fritz J, Leeb BF. Quality of care of rural rheumatoid arthritis patients in Austria. Wien Klin Wochenschr. 2014;126(11-12):360–7.CrossRefPubMed Puchner R, Brezinschek HP, Herold M, Nothnagl T, Studnicka- Benke A, Fritz J, Leeb BF. Quality of care of rural rheumatoid arthritis patients in Austria. Wien Klin Wochenschr. 2014;126(11-12):360–7.CrossRefPubMed
16.
go back to reference Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun. 2010;35(1):10–4.CrossRefPubMed Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun. 2010;35(1):10–4.CrossRefPubMed
17.
go back to reference Symmons DPM. Looking back: rheumatoid arthritis- aetiology, occurrence and mortality. Rheumatology. 2005;44 Suppl 4:iv14–7.PubMed Symmons DPM. Looking back: rheumatoid arthritis- aetiology, occurrence and mortality. Rheumatology. 2005;44 Suppl 4:iv14–7.PubMed
18.
go back to reference Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, Silman AJ. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum. 1999;42(7):1339–46.CrossRefPubMed Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, Silman AJ. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum. 1999;42(7):1339–46.CrossRefPubMed
20.
go back to reference Gormley GJ, Steele WK, Gilliland A, Leggett P, Wright GD, Bell AL, et al. Can diagnostic triage by general practitioners or rheumatology nurses improve the positive predictive value of referrals to early arthritis clinics? Rheumatology (Oxford). 2003;42(6):763–8.CrossRef Gormley GJ, Steele WK, Gilliland A, Leggett P, Wright GD, Bell AL, et al. Can diagnostic triage by general practitioners or rheumatology nurses improve the positive predictive value of referrals to early arthritis clinics? Rheumatology (Oxford). 2003;42(6):763–8.CrossRef
21.
go back to reference Walter E, Zehetmayr S. Guidelines for health-economic evaluations in Austria. Wien Med Wochenschr. 2006;156:23–4. 628-632. Walter E, Zehetmayr S. Guidelines for health-economic evaluations in Austria. Wien Med Wochenschr. 2006;156:23–4. 628-632.
22.
go back to reference Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum. 2004;50(1):55–62.CrossRefPubMed Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum. 2004;50(1):55–62.CrossRefPubMed
23.
go back to reference Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum. 2006;55(6):864–72.CrossRefPubMed Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum. 2006;55(6):864–72.CrossRefPubMed
24.
go back to reference Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65:1175–83.CrossRefPubMedPubMedCentral Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65:1175–83.CrossRefPubMedPubMedCentral
25.
go back to reference Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. 2008;358:661–3.CrossRefPubMed Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. 2008;358:661–3.CrossRefPubMed
26.
go back to reference Huscher D, Mittendorf T, von Hinüber U, Kötter I, Hoese G, Pfäfflin A, for the German Collaborative Arthritis Centres, et al. Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. 2015;74(4):738–45.CrossRefPubMed Huscher D, Mittendorf T, von Hinüber U, Kötter I, Hoese G, Pfäfflin A, for the German Collaborative Arthritis Centres, et al. Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. 2015;74(4):738–45.CrossRefPubMed
27.
go back to reference Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis. 2010;10:1803–8.CrossRef Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis. 2010;10:1803–8.CrossRef
Metadata
Title
Improving patient flow of people with rheumatoid arthritis has the potential to simultaneously improve health outcomes and reduce direct costs
Authors
R. Puchner
R. Hochreiter
H. Pieringer
A. Vavrovsky
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-016-1362-7

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue